Search results for "OSTEOPOROSIS"

showing 10 items of 393 documents

Bisphosphonates and atherosclerosis: why?

2005

The increasing knowledge on bone calcification processes has revealed some similarities with vascular tissue, where calcifications of arteries and cardiac valves contribute to several cardiovascular problems, such as heart failure, systolic hypertension, and myocardial and peripheral ischemic disease. Bisphosphonates have been used extensively for over two decades for the treatment of diseases associated with excessive bone resorption, i.e., osteoporosis, osteolytic bone metastasis, hypercalcemia and Paget’s disease, by blocking osteoclastic function. Etidronate, pamidronate and clodronate has been shown to inhibit the development of experimental atherosclerosis, and proposed mechanisms fo…

medicine.medical_specialtyOsteoporosisMevalonic AcidApoptosisDisease030204 cardiovascular system & hematologyBone resorption03 medical and health sciences0302 clinical medicineRheumatologyCalcinosisInternal medicinemedicineHumansBone ResorptionFoam cell030203 arthritis & rheumatologyDiphosphonatesMolecular Structurebusiness.industryMacrophagesBone metastasisCalcinosismedicine.diseaseAtherosclerosisArterial calcificationEndocrinologyCholesterolHeart failureCancer researchbusinessLupus
researchProduct

Alendronate-associated osteonecrosis of the jaws: a review of the main topics

2013

Bisphosphonates is a group of inorganic pyrophosphates analogues that suppress bone resorption by inducing osteoclast inactivation, being frequently used for management of diseases affecting bone metabolism, bone metastases and bone tumors. However, since 2003 many cases describing the presence of necrotic bone exposures in the jaws have been described in patients receiving these drugs, what represent a significant complication of bisphosphonates treatment. The overall incidence of bisphosphonate-related osteonecrosis of the jaws is low, ranging from 0.7% to 12%, mainly observed in those patients receiving intravenously treatment. Osteonecrosis of the jaws associated to oral bisphosphonate,…

medicine.medical_specialtyOsteoporosisOdontologíaReviewBone resorptionBone remodelingOsteoclastmedicineHumansIn patientGeneral DentistryPathologicalOral Medicine and PathologyAlendronateBone Density Conservation Agentsbusiness.industryNecrotic bonemedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgerymedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryBisphosphonate-Associated Osteonecrosis of the JawComplicationbusiness
researchProduct

Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.

2013

Osteoporosis is characterized by low bone mineral density and/or poor bone microarchitecture leading to an increased risk of fractures. The skeletal alterations in osteoporosis are a consequence of a relative deficit of bone formation compared to bone resorption. Osteoporosis therapies have mostly relied on antiresorptive drugs. An alternative therapeutic approach for osteoporosis is currently available, based on the intermittent administration of parathyroid hormone (PTH). Bone anabolism caused by PTH therapy is mainly accounted for by the ability of PTH to increase osteoblastogenesis and osteoblast survival. PTH and PTH-related protein (PTHrP)-an abundant local factor in bone- interact wi…

medicine.medical_specialtyOsteoporosisParathyroid hormoneBone healingBiochemistryBone resorptionBone remodelingOsteogenesisInternal medicinemedicineAnimalsHumansBone regenerationCell ProliferationReceptor Parathyroid Hormone Type 1PharmacologyBone mineralOsteoblastsBone Density Conservation Agentsbusiness.industryParathyroid Hormone-Related ProteinOsteoblastCell Differentiationmedicine.diseaseProtein Structure Tertiarymedicine.anatomical_structureEndocrinologyGene Expression RegulationParathyroid HormoneOsteoporosisFemalebusinesshormones hormone substitutes and hormone antagonistsSignal TransductionBiochemical pharmacology
researchProduct

Ibandronate: a review of its vertebral and nonvertebral antifracture efficacy.

2009

After the Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE) study had demonstrated the strong vertebral and nonvertebral antifracture efficacy of daily and intermittent oral ibandronate, the Monthly Oral Ibandronate In Ladies (MOBILE) study gave evidence for an increased efficacy on the bone mineral density (BMD) of higher intermittent oral ibandronate doses (150 mg monthly) compared with 2.5 mg daily. The BONE study also observed nonvertebral antifracture efficacy in patients with a high risk for fractures (mean femoral neck T score of −3.0 or less). A recently published meta-analysis assessing the nonvertebral antifracture efficacy corresponding to the …

medicine.medical_specialtyOsteoporosisUrologyIbandronic acidThoracic VertebraeBone DensityMedicineHumansIn patientDosingIbandronic AcidOsteoporosis PostmenopausalFemoral neckBone mineralLumbar VertebraeBone Density Conservation AgentsDiphosphonatesbusiness.industryInjection therapyGeneral Medicinemedicine.diseaseSurgerymedicine.anatomical_structureTolerabilityCervical Vertebraebusinessmedicine.drugWomen's health (London, England)
researchProduct

Medication related osteonecrosis of the jaws (MRONJ): Factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) place…

2020

Background Medication-related osteonecrosis of the jaws (MRONJ) is a well-known complication associated with antiresorptive and antiangiogenic therapies. The purpose of this study was to analyse if there is any predictive factor of recurrence after local debridement plus platelet rich plasma (PRP) placement in MRONJ patients. Material and Methods Seventy MRONJ patients treated at the department of Oral and Maxillofacial Surgery in La Paz Hospital (Madrid, Spain) were included in this retrospective study. All of them were treated surgically by local debridement and PRP placement. The observation period was between January 2012 and January 2019. Information regarding use, type, administration…

medicine.medical_specialtyOsteoporosispain controlpain reliefBreast cancermedicineHumansGeneral DentistryMultiple myelomaalveolar osteitisUNESCO:CIENCIAS MÉDICASAgedRetrospective StudiestreatmentBone Density Conservation AgentsDiphosphonatesbusiness.industryPlatelet-Rich PlasmaResearchRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryZoledronic acidDenosumabOtorhinolaryngologydry socketJawOral and maxillofacial surgerySurgeryBisphosphonate-Associated Osteonecrosis of the JawFemaleOral SurgeryComplicationbusinessMultiple Myelomamanagementmedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct

Acetabulumfrakturen im Alter

2002

Acetabular fractures in elderly patients are rare injuries, but their incidence is increasing. Poor bone quality due to osteoporosis and an increased operative risk due to concomitant disease are factors complicating surgical therapy. Literature does not provide generally accepted treatment protocols. In a 4-year period, 27 patients who were 65 years or older and who had an acute displaced fracture of the acetabulum were admitted to our department. Four minimally displaced and stable fractures were managed conservatively. Internal fixation was performed in 16 cases. According to the Merle d'Aubigne score, in 15 out of 18 surviving patients excellent or good results were found. Treatment str…

medicine.medical_specialtyOsteosynthesisBone diseasebusiness.industrymedicine.medical_treatmentOsteoporosismedicine.diseaseSurgeryFemoral headmedicine.anatomical_structureFracture fixationBone plateEmergency MedicinemedicineInternal fixationOrthopedics and Sports MedicineSurgerybusinessReduction (orthopedic surgery)Der Unfallchirurg
researchProduct

Associated Factors and Liver Disease Severity for Decreased Bone Mineral Density in HIV Mono- and HIV/HCV Co-infected Patients

2015

Objective: We assessed the prevalence and risk factors of decreased bone mineral density (BMD) in patients mono-infected with human immunodeficiency virus (HIV) or co-infected with hepatitis C virus (HIV/HCV). We also evaluated whether bone loss was linked to lipid asset in both groups and to severity of liver fibrosis in the co-infected group. Methods: We consecutively enrolled 194 HIV-patients (129 mono-infected and 65 co-infected). All HIV-patients underwent dual-energy X-ray absorptiometry (DXA), while co-infected patients underwent transient elastography. Advanced liver fibrosis was defined as a median liver stiffness ≥ 9.5 kPa. Fibrosis was also assessed in all the HIV-patients using …

medicine.medical_specialtyPathologyBone densityBone diseaseLiver fibrosisImmunologyOsteoporosisDermatologyGastroenterologyLiver diseaseFibrosisVirologyInternal medicineBone mineral densitymedicineCoinfectionbusiness.industryOsteoporosiHIVHepatitis Cmedicine.diseaseInfectious DiseasesHCVCoinfectionbusinessTransient elastographyJournal of AIDS & Clinical Research
researchProduct

Effects of diet-induced obesity and voluntary wheel running on the microstructure of the murine distal femur

2011

Abstract Background Obesity and osteoporosis, two possibly related conditions, are rapidly expanding health concerns in modern society. Both of them are associated with sedentary life style and nutrition. To investigate the effects of diet-induced obesity and voluntary physical activity we used high resolution micro-computed tomography (μCT) together with peripheral quantitative computed tomography (pQCT) to examine the microstructure of the distal femoral metaphysis in mice. Methods Forty 7-week-old male C57BL/6J mice were assigned to 4 groups: control (C), control + running (CR), high-fat diet (HF), and high-fat diet + running (HFR). After a 21-week intervention, all the mice were sacrifi…

medicine.medical_specialtyPathologyEndocrinology Diabetes and MetabolismOsteoporosisMedicine (miscellaneous)lcsh:TX341-641Clinical nutritionDistal femurSDG 3 - Good Health and Well-beingFemoral metaphysisInternal medicinemedicineQuantitative computed tomographylcsh:RC620-627Nutrition and Dieteticsmedicine.diagnostic_testbusiness.industryResearchmedicine.diseaseObesitylcsh:Nutritional diseases. Deficiency diseasesEndocrinologyWheel runningSedentary life style/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingbusinesslcsh:Nutrition. Foods and food supplyNutrition & Metabolism
researchProduct

Osteoporosis in men: a case report

2010

Osteoporosis in men is frequently not considered, underdiagnosed and often undertreated. In contrast with osteoporosis occurring in women, the genesis is frequently secondary (30-60%) with a complex diagnostic approach. A careful anamnesis and physical examination associated with laboratory and instrumental evaluation are necessary for an accurate diagnosis. The clinical case presented concerns a 70-year-old man with negative family history for osteoporosis and a personal history of depression, HBV carrier, and chronic obstructive pulmonary disease (COPD) in a heavy ex-smoker with history of alcoholism. The comprehensive geriatric evaluation allowed us to diagnose a multifactorially seconda…

medicine.medical_specialtyPediatricsAlcohol abuseOsteoporosisMedicine (miscellaneous)Alcohol abusePhysical examinationMale osteoporosis; Alcohol abuse; Osteomalacia; Malnutrition; Chronic obstructive pulmonary diseaseMedicineMale osteoporosisFamily historyDepression (differential diagnoses)COPDOsteomalacialcsh:R5-920medicine.diagnostic_testbusiness.industryChronic obstructive pulmonary diseaseMalnutritionmedicine.diseaseOsteomalaciaPhysical therapyBusiness Management and Accounting (miscellaneous)Secondary osteoporosisClinical Medicinebusinesslcsh:Medicine (General)Clinical Management Issues
researchProduct

2015

Recent data suggest that the traditional definition of bisphosphonate-associated osteonecrosis of the jaw (ONJ) may exclude patients who present with the non-exposed variant of the condition. To test the hypothesis that a proportion of patients with ONJ remain undiagnosed because their symptoms do not conform to the traditional case definition, we did a secondary analysis of data from MISSION (Multicentre study on phenotype, definition and classification of osteonecrosis of the jaws associated with bisphosphonates), a cross-sectional study of a large population of patients with bisphosphonate-associated ONJ who were recruited in 13 European centres. Patients with exposed and non-exposed ONJ…

medicine.medical_specialtyPediatricsBisphosphonate-associated osteonecrosis of the jawCross-sectional studybusiness.industryOsteoporosisLarge populationmedicine.diseaseSurgeryExact testOtorhinolaryngologySecondary analysisAntiresorptive AgentsmedicineSurgeryOral SurgeryOsteonecrosis of the jawbusinessBritish Journal of Oral and Maxillofacial Surgery
researchProduct